ANEBULO PHARMACEUTICALS INC's ticker is ANEB and the CUSIP is 034569103. A total of 15 filers reported holding ANEBULO PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 22NW, LP | 3,362,713 | $17,486,000 | 9.28% |
| LVW Advisors, LLC | 700,000 | $3,640,000 | 0.74% |
| Ikarian Capital, LLC | 181,199 | $942,000 | 0.17% |
| MANGROVE PARTNERS IM, LLC | 399,219 | $2,076,000 | 0.10% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,333 | $90,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 7,141 | $37,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 20 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 2,909 | $15,000 | 0.00% |
| BlackRock Inc. | 7,333 | $38,000 | 0.00% |